Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impact of the environment on multiple sclerosis.
Inter- and intra-laboratory comparison of JC polyomavirus antibody testing using two different virus-like particle (VLP)-based assays.
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Demyelinating encephalopathy in adult onset Still's disease: Case report and review of the literatures.
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
Traumatic injury and multiple sclerosis: a systematic review and meta-analysis.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report.
Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia.
CNS neuroimmunology seen by a neuropathologist.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Fingolimod May Protect Neurons from Degeneration
Validation of an Arabic version of Fatigue Severity Scale.
Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
A rare case of multiple sclerosis and McArdle disease.
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Pages
« first
‹ previous
…
457
458
459
460
461
462
463
464
465
…
next ›
last »